Comparison of Patient-Controlled Epidural Analgesia with Intravenous Patient-Controlled Analgesia on Postoperative Pain Control after Major Gynecologic Oncologic Surgery-A Randomized controlled clinical trial

Early Phase 1

• Conditions: Postoperative Pain Control after Gynecologic Oncologic Surgery.; Malignant neoplasms of female genital organs; C51-58

• Registration Number: IRCT2013071411700N2
• Lead Sponsor: Women's Reproductive Health Research Center, Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

Women’s with gynecologic Oncologic Surgery in the operation list of Alzahra Hospital; Women’s with ASA class I and II; patients who wannt to contribute in the study

Exclusion criteria:
Women’s with ASA class III or higher; Severe cardiovascular diseases; Epidural anesthesia contraindications;Coagulation disorders or antiquagulant drugs using with therapeutic dose; Spin anomalies; Sepsis; Hypovolemic shock

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Postoperative analgesia. Timepoint: Postoperative 2, 4, 6, 8, 12, 24 and 36 hours. Method of measurement: Severity os pain with Visual Analoge Scale(VAS).

Secondary Outcome Measures

Name	Time	Method
Sedation. Timepoint: Posoperative 4, 6, 8, 12, 24, 36 hours. Method of measurement: Modified Ramsy sedation scale.;Patient's satisfaction. Timepoint: On the fifth day postoperative. Method of measurement: Score according to postoperative analgesia (nil = 0;.;Nausea and vomiting. Timepoint: Postoperative 2, 4, 6, 8, 12, 24, 36 hours. Method of measurement: Severity of Nausea and vomiting with Belville scorhng.